Eikon Therapeutics, Inc.
Public company- Headquarters
- MILLBRAE, California
- Industry
- Biotechnology
- Ticker
- EIKN
- CIK
- 0001861123
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| DirectorLeon Chen, Ph.D. | Aug 3, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Executive departure
Director departs: Leon Chen, Ph.D.
Leon Chen, Ph.D., Director of Eikon Therapeutics, Inc., resigns the role, effective July 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 3, 2026Role: Director
- Executive departure
Director departs: Joshua Wolfe
Joshua Wolfe, Director of Eikon Therapeutics, Inc., resigns the role, effective July 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 3, 2026Role: Director
layoffs from Jul 21, 2025
WARN noticeWARN notice: CA
Eikon Therapeutics Inc. filed a WARN notice with the California WARN list on May 21, 2025 covering 55 workers. The layoffs take effect on Jul 21, 2025.
Source: California WARN list, filed May 21, 2025Site: CA
Workers affected: 55
Last verified Nov 8, 2026